Kestra Medical Technologies, Ltd. (KMTS) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 3 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for KMTS is $28.00, representing a +41.8% upside from the current price of $19.74. Price targets range from a low of $24.00 to a high of $30.00.
